| |
| |
|
| Insider
Information: |
Nanavaty Maulik |
| Relationship: |
|
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
177,758 |
|
|
Indirect Shares
|
11,017 |
|
|
| Direct
Value |
$13,232,310 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
188,775 |
|
|
| Total
Value |
$13,232,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 6.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-01-02 |
4 |
AS |
$45.33 |
$436,214 |
D/D |
(9,623) |
260,219 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-01-02 |
4 |
OE |
$13.08 |
$147,239 |
D/D |
9,623 |
269,842 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-01-03 |
4 |
AS |
$44.73 |
$224,757 |
D/D |
(5,025) |
255,194 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-03 |
4 |
AS |
$42.17 |
$405,802 |
D/D |
(9,623) |
255,194 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-03 |
4 |
OE |
$16.31 |
$156,951 |
D/D |
9,623 |
264,817 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-14 |
4 |
D |
$42.31 |
$266,553 |
D/D |
(6,300) |
262,334 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
13,440 |
268,634 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-15 |
4 |
D |
$42.31 |
$34,863 |
D/D |
(824) |
263,171 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
263,995 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,713 |
264,884 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-21 |
4 |
D |
$42.62 |
$36,227 |
D/D |
(850) |
264,034 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-22 |
4 |
D |
$42.62 |
$39,807 |
D/D |
(934) |
264,983 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,883 |
265,917 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-23 |
4 |
D |
$42.62 |
$38,912 |
D/D |
(913) |
265,910 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,840 |
266,823 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-28 |
4 |
D |
$37.39 |
$30,211 |
D/D |
(808) |
266,731 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,629 |
267,539 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-03-02 |
4 |
AS |
$37.47 |
$628,183 |
D/D |
(16,763) |
259,591 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-03-02 |
4 |
OE |
$16.31 |
$156,951 |
D/D |
9,623 |
276,354 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-08-28 |
4 |
S |
$40.45 |
$1,537,165 |
D/D |
(38,000) |
228,993 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-08-28 |
4 |
OE |
$17.26 |
$118,248 |
D/D |
6,851 |
266,993 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-01-01 |
4 |
D |
$35.95 |
$130,319 |
D/D |
(3,625) |
235,159 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,791 |
238,784 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-10 |
4 |
D |
$38.85 |
$87,024 |
D/D |
(2,240) |
239,396 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,477 |
241,636 |
0 |
- |
|
176 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
